Processing

Please wait...

PATENTSCOPE will be unavailable a few hours for maintenance reason on Saturday 31.10.2020 at 7:00 AM CET
Settings

Settings

Goto Application

1. WO2006095906 - IMMUNOSUPPRESSIVE AGENT AND ANTI-TUMOR AGENT COMPRISING HETEROCYCLIC COMPOUND AS ACTIVE INGREDIENT

Publication Number WO/2006/095906
Publication Date 14.09.2006
International Application No. PCT/JP2006/304937
International Filing Date 13.03.2006
IPC
A61K 31/5377 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
535having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
53751,4-Oxazines, e.g. morpholine
5377not condensed and containing further heterocyclic rings, e.g. timolol
A61P 1/04 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
1Drugs for disorders of the alimentary tract or the digestive system
04for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
A61P 17/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
17Drugs for dermatological disorders
A61P 19/02 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
19Drugs for skeletal disorders
02for joint disorders, e.g. arthritis, arthrosis
A61P 29/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
29Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (NSAIDs)
A61P 37/02 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
37Drugs for immunological or allergic disorders
02Immunomodulators
CPC
A61K 31/5377
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
535having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
53751,4-Oxazines, e.g. morpholine
5377not condensed and containing further heterocyclic rings, e.g. timolol
A61P 1/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
1Drugs for disorders of the alimentary tract or the digestive system
A61P 1/04
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
1Drugs for disorders of the alimentary tract or the digestive system
04for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
A61P 1/16
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
1Drugs for disorders of the alimentary tract or the digestive system
16for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
A61P 11/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
11Drugs for disorders of the respiratory system
A61P 11/06
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
11Drugs for disorders of the respiratory system
06Antiasthmatics
Applicants
  • 全薬工業株式会社 ZENYAKU KOGYO KABUSHIKIKAISHA [JP]/[JP] (AllExceptUS)
  • 春田 和彦 HARUTA, Kazuhiko [JP]/[JP] (UsOnly)
  • 矢口 信一 YAGUCHI, Shinichi [JP]/[JP] (UsOnly)
  • 松野 俊行 MATSUNO, Toshiyuki [JP]/[JP] (UsOnly)
  • 土田 良雄 TSUCHIDA, Yoshio [JP]/[JP] (UsOnly)
  • 渡辺 哲夫 WATANABE, Tetsuo [JP]/[JP] (UsOnly)
  • 吉岡 君友 YOSHIOKA, Kimitomo [JP]/[JP] (UsOnly)
  • 油井 龍五 YUI, Ryogo [JP]/[JP] (UsOnly)
Inventors
  • 春田 和彦 HARUTA, Kazuhiko
  • 矢口 信一 YAGUCHI, Shinichi
  • 松野 俊行 MATSUNO, Toshiyuki
  • 土田 良雄 TSUCHIDA, Yoshio
  • 渡辺 哲夫 WATANABE, Tetsuo
  • 吉岡 君友 YOSHIOKA, Kimitomo
  • 油井 龍五 YUI, Ryogo
Agents
  • 園田 吉隆 SONODA, Yoshitaka
Priority Data
2005-06925511.03.2005JP
Publication Language Japanese (JA)
Filing Language Japanese (JA)
Designated States
Title
(EN) IMMUNOSUPPRESSIVE AGENT AND ANTI-TUMOR AGENT COMPRISING HETEROCYCLIC COMPOUND AS ACTIVE INGREDIENT
(FR) AGENT IMMUNOSUPPRESSIF ET AGENT ANTI-TUMORAL COMPRENANT UN COMPOSE HETEROCYCLIQUE EN TANT QUE PRINCIPE ACTIF
(JA) 複素環式化合物を有効成分とする免疫抑制剤及び抗腫瘍剤
Abstract
(EN)
A novel immunosuppressive agent, more specifically an immunosuppressive agent comprising, as an active ingredient, a heterocyclic compound represented by the general formula (I) (wherein X or other variables are as defined in the specification) or a pharmaceutically acceptable salt thereof; a novel heterocyclic compound represented by the general formula (II) (wherein X or other variables are as defined in the specification) or a pharmaceutically acceptable salt thereof; and use of the compound or salt as an anti-tumor agent.
(FR)
L’invention concerne un agent immunosuppressif, plus spécifiquement un agent immunosuppressif comprenant, en tant que principe actif, un composé hétérocyclique représenté par la formule générale (I) (dans laquelle X ou d’autres variables sont tels que définis dans la description) ou un sel pharmaceutiquement acceptable de celui-ci ; un nouveau composé hétérocyclique représenté par la formule générale (II) (dans laquelle X ou d’autres variables sont tels que définis dans la description) ou un sel pharmaceutiquement acceptable de celui-ci ; et l’utilisation du composé ou sel en tant qu’agent anti-tumoral.
(JA)
not available
Latest bibliographic data on file with the International Bureau